NUT Project: Nutritional Support in Thoracic Cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational program follows patients from diagnosis to treatment, focusing on nutritional status and the impact of dietetic support. An initial nutritional risk screen (NRS-2002) determines whether patients receive a formal nutritional assessment. Those with higher risk (NRS-2002 score ≥ 3) undergo a GLIM-based malnutrition assessment and receive individualized dietary and nutritional care. The study tracks routine clinical care and does not assign experimental treatments, relying on real-world practice to observe nutritional management alongside cancer therapy. Results may inform how nutrition care integrates with thoracic oncology treatment pathways.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Men and women aged ≥ 18 years,
* Diagnosis of advanced/metastatic non-small cell and small cell lung cancer candidates for first-line treatment of thoracic cancer
* High nutritional risk according to NRS2002 screening test (score ≥3)
* Nutritional assessment and care at the center
* Sign Informed Consent

Exclusion Criteria:

* Lack of availability of information regarding anamnestic data,
* Failure to sign informed consent

Where it's running

• Ospedale P. Pederzoli Casa di Cura Privata S.p.A.
  Peschiera del Garda, Verona, Italy Recruiting

Study contacts

• Study coordinator: Elisa Roca, MD
• Email: urc@ospedalepederzoli.it
• Phone: +39 0456444193

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Integrated genomic and clinical database for cancer biomarker discovery

  Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.

  Recruiting Samsung Medical Center · Seoul, Gang-Nam · NCT07911267

• Understanding what patients want from NSCLC treatment monitoring

  Researchers are testing how patients with non-small cell lung cancer feel about and prefer monitoring their symptoms during treatment, with input from patients, caregivers, and clinicians.

  Recruiting European Institute of Oncology · Milan, mI · NCT07909343

• PD-L1-targeted PET probe to map PD-L1 in solid tumors

  A PET tracer called 18F-F-PDL1-3 is being tested to see if it can detect PD-L1 expression in primary and metastatic tumors to help guide personalized treatment.

  Recruiting Phase 2 Peking University Cancer Hospital & Institute · Beijing · NCT07848243

• Cardiorespiratory fitness after lobectomy versus sublobar resection in NSCLC

  This study tests how different lung surgeries (lobectomy vs. sublobar resection) affect fitness levels after surgery in people with non-small cell lung cancer.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07841249

• CAIX-targeted PET/CT imaging in solid tumors

  Researchers are testing a CAIX-targeted PET/CT imaging agent to see if it detects and reflects CAIX levels in solid tumors like clear cell renal cell carcinoma, NSCLC, and breast cancer.

  Recruiting Zhongnan Hospital · Wuhan, Hubei · NCT07833085

• Single-Port Robotic Lobectomy for Early-Stage NSCLC

  This study tests the safety and outcomes of using the da Vinci Single-Port system for lobectomy and lymph node dissection in people with early-stage non-small cell lung cancer.

  Recruiting European Institute of Oncology · Milan, Mi · NCT07790406

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.